Global Prescription Drugs Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report aims to provide a comprehensive presentation of the global market for Prescription Drugs, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Drugs.
The Prescription Drugs market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Prescription Drugs market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prescription Drugs manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
The global Prescription Drugs market size in 2022 is 800.0 million US dollars, and it is expected to be 1416.1 million US dollars by 2029, with a compound annual growth rate of 8.50% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Prescription Drugs market include Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Ireland), Sanofi (France), Pfizer Inc. (U.S.), and GlaxoSmithKline PLC (UK). The share of the top 3 players in the Prescription Drugs market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Prescription Drugs market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Branded accounted for XX% of Prescription Drugs market in 2022. Generic share of XX%.
Oral accounted for XX% of the Prescription Drugs market in 2022. Topical accounts for XX%.
Chapter Outline
Chapters 1-2: Introduces the product overview, market scope, product classification, application, and regional division.
Chapter 3: Analysis of the competitive environment of Prescription Drugs market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the players' M&A and expansion in recent years.
Chapter 4: Provide global Prescription Drugs market value, volume and price data by region.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Prescription Drugs market country segmentation data.
Chapter 10: Analyzes the main companies in the Prescription Drugs industry, including their main businesses, products/services, sales, prices, revenue, gross margin, and the latest developments.
Chapter 11: Analyzes the Prescription Drugs manufacturing cost, including raw material analysis, manufacturing cost structure, and market dynamics.
Chapter 12: Analyzes the Prescription Drugs industry chain, including marketing channels, distributors and major downstream buyers.
Chapter 13: The main points and conclusions of the report.
Chapter 14: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
South America
Brazil
Argentina
Colombia
MEA
Saudi Arabia
Egypt
Nigeria
Player list
Mylan N.V. (U.S.)
Teva Pharmaceutical Industries Ltd. (Ireland)
Sanofi (France)
Pfizer Inc. (U.S.)
GlaxoSmithKline PLC (UK)
Novartis AG (Switzerland)
Merck & Co. Inc. (U.S.)
Types list
Branded
Generic
Application list
Oral
Topical
Parenteral
Other Routes of Administration
Table of Content
1 Prescription Drugs Market Overview
1.1 Prescription Drugs Product Description
1.2 Prescription Drugs Market Segment by Type
1.3 Global Prescription Drugs Market Size by Type
1.3.1 Global Prescription Drugs Market Size Overview by Type
1.3.2 Global Prescription Drugs Historic Market Size Review by Type
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Prescription Drugs Sales Breakdown by Type
1.4.2 Europe Prescription Drugs Sales Breakdown by Type
1.4.3 Asia-Pacific Prescription Drugs Sales Breakdown by Type
1.4.4 Latin America Prescription Drugs Sales Breakdown by Type
1.4.5 Middle East and Africa Prescription Drugs Sales Breakdown by Type
2 Global Prescription Drugs by Application
2.1 Prescription Drugs Market Segment by Application
2.2 Global Prescription Drugs Market Size by Application
2.2.1 Global Prescription Drugs Market Size Overview by Application
2.2.2 Global Prescription Drugs Historic Market Size Review by Application
2.3 Key Regions Market Size Segment by Application
2.3.1 North America Prescription Drugs Sales Breakdown by Application
2.3.2 Europe Prescription Drugs Sales Breakdown by Application
2.3.3 Asia-Pacific Prescription Drugs Sales Breakdown by Application
2.3.4 Latin America Prescription Drugs Sales Breakdown by Application
2.3.5 Middle East and Africa Prescription Drugs Sales Breakdown by Application
3 Prescription Drugs Status and Outlook by Region
3.1 Global Prescription Drugs Market Size and CAGR by Region: 2018 VS 2023 VS 2029
3.2 Global Prescription Drugs Historic Market Size by Region
3.2.1 Global Prescription Drugs Sales in Volume by Region
3.2.2 Global Prescription Drugs Sales in Value by Region
3.2.3 Global Prescription Drugs Sales Price and Gross Margin
3.3 Global Prescription Drugs Forecasted Market Size by Region
3.3.1 Global Prescription Drugs Sales in Volume by Region
3.3.2 Global Prescription Drugs Sales in Value by Region
3.3.3 Global Prescription Drugs Sales Price and Gross Margin
4 Global Prescription Drugs Market Competition by Company
4.1 Global Top Players by Prescription Drugs Sales
4.2 Global Top Players by Prescription Drugs Revenue
4.3 Global Top Players Prescription Drugs Price
4.4 Global Top Manufacturers Prescription Drugs Manufacturing Base Distribution, Sales Area, Product Type
4.5 Prescription Drugs Market Competitive Situation and Trends
4.5.1 Prescription Drugs Market Concentration Rate
4.5.2 Global 3 and 6 Largest Manufacturers by Prescription Drugs Sales and Revenue in 2022
4.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prescription Drugs as of 2022)
4.7 Date of Key Manufacturers Enter into Prescription Drugs Market
4.8 Key Manufacturers Prescription Drugs Product Offered
4.9 Mergers & Acquisitions, Expansion
5 North America Prescription Drugs by Country
5.1 North America Prescription Drugs Historic Market Size by Country
5.1.1 North America Prescription Drugs Sales in Volume by Country
5.1.2 North America Prescription Drugs Sales in Value by Country
5.2 North America Prescription Drugs Forecasted Market Size by Country
5.2.1 North America Prescription Drugs Sales in Volume by Country
5.2.2 North America Prescription Drugs Sales in Value by Country
6 Europe Prescription Drugs by Country
6.1 Europe Prescription Drugs Historic Market Size by Country
6.1.1 Europe Prescription Drugs Sales in Volume by Country
6.1.2 Europe Prescription Drugs Sales in Value by Country
6.2 Europe Prescription Drugs Forecasted Market Size by Country
6.2.1 Europe Prescription Drugs Sales in Volume by Country
6.2.2 Europe Prescription Drugs Sales in Value by Country
7 Asia-Pacific Prescription Drugs by Country
7.1 Asia-Pacific Prescription Drugs Historic Market Size by Country
7.1.1 Asia-Pacific Prescription Drugs Sales in Volume by Country
7.1.2 Asia-Pacific Prescription Drugs Sales in Value by Country
7.2 Asia-Pacific Prescription Drugs Forecasted Market Size by Country
7.2.1 Asia-Pacific Prescription Drugs Sales in Volume by Country
7.2.2 Asia-Pacific Prescription Drugs Sales in Value by Country
8 Latin America Prescription Drugs by Country
8.1 Latin America Prescription Drugs Historic Market Size by Country
8.1.1 Latin America Prescription Drugs Sales in Volume by Country
8.1.2 Latin America Prescription Drugs Sales in Value by Country
8.2 Latin America Prescription Drugs Forecasted Market Size by Country
8.2.1 8.2.1 Latin America Prescription Drugs Sales in Volume by Country
8.2.2 8.2.2 Latin America Prescription Drugs Sales in Value by Country
9 Middle East and Africa Prescription Drugs by Country
9.1 Middle East and Africa Prescription Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Prescription Drugs Sales in Volume by Country
9.1.2 Middle East and Africa Prescription Drugs Sales in Value by Country
9.2 Middle East and Africa Prescription Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Prescription Drugs Sales in Volume by Country
9.2.2 Middle East and Africa Prescription Drugs Sales in Value by Country
10 Manufacturers Profiles
10.1 Mylan N.V. (U.S.)
10.1.1 Mylan N.V. (U.S.) Information
10.1.2 Business Overview
10.1.3 Mylan N.V. (U.S.) Prescription Drugs Sales, Price, Revenue, Gross Margin
10.1.4 Prescription Drugs Products Offered
10.1.5 Mylan N.V. (U.S.) Recent Development
10.2 Teva Pharmaceutical Industries Ltd. (Ireland)
10.2.1 Teva Pharmaceutical Industries Ltd. (Ireland) Information
10.2.2 Business Overview
10.2.3 Teva Pharmaceutical Industries Ltd. (Ireland) Prescription Drugs Sales, Price, Revenue, Gross Margin
10.2.4 Prescription Drugs Products Offered
10.2.5 Teva Pharmaceutical Industries Ltd. (Ireland) Recent Development
10.3 Sanofi (France)
10.3.1 Sanofi (France) Information
10.3.2 Business Overview
10.3.3 Sanofi (France) Prescription Drugs Sales, Price, Revenue, Gross Margin
10.3.4 Prescription Drugs Products Offered
10.3.5 Sanofi (France) Recent Development
10.4 Pfizer Inc. (U.S.)
10.4.1 Pfizer Inc. (U.S.) Information
10.4.2 Business Overview
10.4.3 Pfizer Inc. (U.S.) Prescription Drugs Sales, Price, Revenue, Gross Margin
10.4.4 Prescription Drugs Products Offered
10.4.5 Pfizer Inc. (U.S.) Recent Development
10.5 GlaxoSmithKline PLC (UK)
10.5.1 GlaxoSmithKline PLC (UK) Information
10.5.2 Business Overview
10.5.3 GlaxoSmithKline PLC (UK) Prescription Drugs Sales, Price, Revenue, Gross Margin
10.5.4 Prescription Drugs Products Offered
10.5.5 GlaxoSmithKline PLC (UK) Recent Development
10.6 Novartis AG (Switzerland)
10.6.1 Novartis AG (Switzerland) Information
10.6.2 Business Overview
10.6.3 Novartis AG (Switzerland) Prescription Drugs Sales, Price, Revenue, Gross Margin
10.6.4 Prescription Drugs Products Offered
10.6.5 Novartis AG (Switzerland) Recent Development
10.7 Merck & Co. Inc. (U.S.)
10.7.1 Merck & Co. Inc. (U.S.) Information
10.7.2 Business Overview
10.7.3 Merck & Co. Inc. (U.S.) Prescription Drugs Sales, Price, Revenue, Gross Margin
10.7.4 Prescription Drugs Products Offered
10.7.5 Merck & Co. Inc. (U.S.) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Prescription Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Prescription Drugs Industrial Chain Analysis
11.4 Prescription Drugs Market Dynamics
11.4.1 Prescription Drugs Industry Trends
11.4.2 Prescription Drugs Growth Drivers
11.4.3 Prescription Drugs Market Challenges
11.4.4 Prescription Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Prescription Drugs Distributors
12.3 Prescription Drugs Downstream Customers
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer
Tables & Figures:
List of Tables and Figures
Figure Global Prescription Drugs Market Size Overview by Type
Table Global Prescription Drugs Sales Breakdown in Volume, by Type
Table Global Prescription Drugs Sales Breakdown in Value, by Type
Table Global Prescription Drugs Average Selling Price (ASP) by Type
Table Global Prescription Drugs Sales Breakdown in Volume, by Type (2023-2029)
Table Global Prescription Drugs Sales Breakdown in Value, by Type (2023-2029)
Table Global Prescription Drugs Average Selling Price (ASP) by Type (2023-2029)
Table North America Prescription Drugs Sales Breakdown in Volume, by Type
Table Europe Prescription Drugs Sales Breakdown in Volume, by Type
Table Asia-Pacific Prescription Drugs Sales Breakdown in Volume, by Type
Table Latin America Prescription Drugs Sales Breakdown in Volume, by Type
Table Middle East and Africa Prescription Drugs Sales Breakdown in Volume, by Type
Figure Global Prescription Drugs Market Size Overview by Application
Table Global Prescription Drugs Sales Breakdown in Volume, by Application
Table Global Prescription Drugs Sales Breakdown in Value, by Application
Table Global Prescription Drugs Average Selling Price (ASP) by Application
Table Global Prescription Drugs Sales Breakdown in Volume, by Application (2023-2029)
Table Global Prescription Drugs Sales Breakdown in Value, by Application (2023-2029)
Table Global Prescription Drugs Average Selling Price (ASP) by Application (2023-2029)
Table North America Prescription Drugs Sales Breakdown in Volume, by Application
Table Europe Prescription Drugs Sales Breakdown in Volume, by Application
Table Asia-Pacific Prescription Drugs Sales Breakdown in Volume, by Application
Table Latin America Prescription Drugs Sales Breakdown in Volume, by Application
Table Middle East and Africa Prescription Drugs Sales Breakdown in Volume, by Application
Table Global Prescription Drugs Market Size and CAGR by Region: 2018 VS 2023 VS 2029
Table Global Prescription Drugs Sales in Volume by Region
Table Global Prescription Drugs Sales in Value by Region
Table Global Prescription Drugs Sales Price and Gross Margin
Table Global Prescription Drugs Sales in Volume by Region
Table Global Prescription Drugs Sales in Value by Region
Table Global Prescription Drugs Sales Price and Gross Margin
Table Global Top Players by Prescription Drugs Sales
Table Global Top Players by Prescription Drugs Revenue
Table Global Top Players by Prescription Drugs Price
Table Global Top Manufacturers Prescription Drugs Manufacturing Base Distribution, Sales Area, Product Type
Table Prescription Drugs Market Concentration Rate
Figure Global 5 and 10 Largest Manufacturers by Prescription Drugs Sales and Revenue in 2022
Table Date of Key Manufacturers Enter into Prescription Drugs Market
Table Key Manufacturers Prescription Drugs Product Offered
Table Mergers & Acquisitions, Expansion Plans
Table North America Prescription Drugs Sales in Volume by Country
Table North America Prescription Drugs Sales in Value by Country
Table North America Prescription Drugs Sales in Volume by Country
Table North America Prescription Drugs Sales in Value by Country
Table Europe Prescription Drugs Sales in Volume by Country
Table Europe Prescription Drugs Sales in Value by Country
Table Europe Prescription Drugs Sales in Volume by Country
Table Europe Prescription Drugs Sales in Value by Country
Table Asia-Pacific Prescription Drugs Sales in Volume by Country
Table Asia-Pacific Prescription Drugs Sales in Value by Country
Table Asia-Pacific Prescription Drugs Sales in Volume by Country
Table Asia-Pacific Prescription Drugs Sales in Value by Country
Table Latin America Prescription Drugs Sales in Volume by Country
Table Latin America Prescription Drugs Sales in Value by Country
Table Latin America Prescription Drugs Sales in Volume by Country
Table Latin America Prescription Drugs Sales in Value by Country
Table Middle East and Africa Prescription Drugs Sales in Volume by Country
Table Middle East and Africa Prescription Drugs Sales in Value by Country
Table Middle East and Africa Prescription Drugs Sales in Volume by Country
Table Middle East and Africa Prescription Drugs Sales in Value by Country
Table Mylan N.V. (U.S.) Basic Information, Manufacturing Base
Table Mylan N.V. (U.S.) Prescription Drugs Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Mylan N.V. (U.S.) Sales and Growth Rate
Figure Mylan N.V. (U.S.) Revenue Market Share 2018-2023
Table Prescription Drugs Products Offered
Table Mylan N.V. (U.S.) Recent Development
Table Teva Pharmaceutical Industries Ltd. (Ireland) Basic Information, Manufacturing Base
Table Teva Pharmaceutical Industries Ltd. (Ireland) Prescription Drugs Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Teva Pharmaceutical Industries Ltd. (Ireland) Sales and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. (Ireland) Revenue Market Share 2018-2023
Table Prescription Drugs Products Offered
Table Teva Pharmaceutical Industries Ltd. (Ireland) Recent Development
Table Sanofi (France) Basic Information, Manufacturing Base
Table Sanofi (France) Prescription Drugs Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Sanofi (France) Sales and Growth Rate
Figure Sanofi (France) Revenue Market Share 2018-2023
Table Prescription Drugs Products Offered
Table Sanofi (France) Recent Development
Table Pfizer Inc. (U.S.) Basic Information, Manufacturing Base
Table Pfizer Inc. (U.S.) Prescription Drugs Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Pfizer Inc. (U.S.) Sales and Growth Rate
Figure Pfizer Inc. (U.S.) Revenue Market Share 2018-2023
Table Prescription Drugs Products Offered
Table Pfizer Inc. (U.S.) Recent Development
Table GlaxoSmithKline PLC (UK) Basic Information, Manufacturing Base
Table GlaxoSmithKline PLC (UK) Prescription Drugs Sales, Price, Revenue, Gross Margin (2018-2023)
Figure GlaxoSmithKline PLC (UK) Sales and Growth Rate
Figure GlaxoSmithKline PLC (UK) Revenue Market Share 2018-2023
Table Prescription Drugs Products Offered
Table GlaxoSmithKline PLC (UK) Recent Development
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base
Table Novartis AG (Switzerland) Prescription Drugs Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Novartis AG (Switzerland) Sales and Growth Rate
Figure Novartis AG (Switzerland) Revenue Market Share 2018-2023
Table Prescription Drugs Products Offered
Table Novartis AG (Switzerland) Recent Development
Table Merck & Co. Inc. (U.S.) Basic Information, Manufacturing Base
Table Merck & Co. Inc. (U.S.) Prescription Drugs Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Merck & Co. Inc. (U.S.) Sales and Growth Rate
Figure Merck & Co. Inc. (U.S.) Revenue Market Share 2018-2023
Table Prescription Drugs Products Offered
Table Merck & Co. Inc. (U.S.) Recent Development
Table Key Raw Materials Price
Table Key Suppliers of Raw Materials
Figure Proportion of Manufacturing Cost Structure
Table Prescription Drugs Chain Analysis
Figure Marketing Channel
Table Major Distributors of Prescription Drugs with Contact Information
Table Major Customers of Prescription Drugs with Contact Information
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
Research Methodology:
Prescription Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|